Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Axogen (AXGN)

Axogen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AXGN
DateTimeSourceHeadlineSymbolCompany
16/05/202412:00GlobeNewswire Inc.Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
14/05/202412:00GlobeNewswire Inc.Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads ConferenceNASDAQ:AXGNAxogen Inc
02/05/202412:00GlobeNewswire Inc.Axogen, Inc Reports First Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
29/04/202421:50GlobeNewswire Inc.Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
16/04/202412:00GlobeNewswire Inc.Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:AXGNAxogen Inc
08/03/202422:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
08/03/202422:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
08/03/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
07/03/202423:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
07/03/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
06/03/202413:59Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
06/03/202413:53Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AXGNAxogen Inc
06/03/202413:45Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AXGNAxogen Inc
05/03/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
05/03/202421:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
05/03/202412:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
05/03/202412:00GlobeNewswire Inc.Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial ResultsNASDAQ:AXGNAxogen Inc
23/02/202421:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
23/02/202421:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
23/02/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
14/02/202420:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
13/02/202421:30GlobeNewswire Inc.Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024NASDAQ:AXGNAxogen Inc
12/02/202418:21Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXGNAxogen Inc
06/02/202422:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
02/02/202421:15GlobeNewswire Inc.Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
02/02/202414:29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
26/01/202416:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
18/01/202422:00GlobeNewswire Inc.Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve CapNASDAQ:AXGNAxogen Inc
11/01/202422:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
11/01/202422:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
 Showing the most relevant articles for your search:NASDAQ:AXGN